COVID-19 Health Evidence Summary No.85 by Millington, Kerry & Reddin, Samantha







Health  Evidence  Summary  No.85  
Kerry  Millington  &  Samantha  Reddin  
Liverpool  School  of  Tropical  Medicine  (LSTM)  &  Institute  of  Development  Studies  
23  July  2020  
  
This  weekly  COVID-­19  health  evidence  summary  (HES)  is  based  on  3.5  hours  of  desk-­based  
research.  The  summary  is  not  intended  to  be  a  comprehensive  summary  of  available  evidence  
on  COVID-­19  but  aims  to  make  original  documents  easily  accessible  to  decision  makers  which,  if  
relevant  to  them,  they  should  go  to  before  making  decisions.  
  
Epidemiology  and  modelling  
Publication	  
date	  
Title/URL	   Journal/Article	  type	   Summary	   Keywords	  












Research	  |	  not	  yet	  
peer	  reviewed	  
•   A	  summary	  of	  open	  
access	  health	  facility	  
location	  data	  in	  Africa	  
using	  re-­‐useable	  code	  to	  
support	  data	  analysts	  
developing	  software	  
tools	  to	  address	  C19	  
response	  in	  individual	  
countries	  
•   Open	  health	  facility	  lists	  
need	  to	  be	  combined	  
with	  other	  open	  or	  
proprietary	  datasets	  to	  
address	  specific	  
questions	  such	  as	  those	  





Infection  Prevention  and  Control  
Publicatio
n	  date	  
Title/URL	   Journal/Article	  
type	  
Summary	   Keywords	   	  	  
16.07.20	   A  
vulnerability  
index  for  the  
managemen
t  of  and  
The	  Lancet	  Global	  
Health	  |	  Article	  
	  	  
•   This	  study	  developed	  a	  
composite	  measure	  of	  
community-­‐level	  
vulnerability	  concerning	  
the	  C19	  situation	  in	  India	  
Vulnerability,	  
resources	  





in  India:  an  
ecological  
study 	  
•   The	  provision	  of	  state	  
and	  district	  ranking	  to	  
policy	  makers	  will	  help	  
prioritise	  resource	  
allocation,	  in	  the	  context	  
of	  constrained	  resources	  








Title/URL	   Journal/Article	  
type	  
Summary	   Keywords	  
















•   A	  robust	  serological	  test	  to	  
detect	  neutralising	  
antibodies	  to	  SARS-­‐CoV-­‐2	  
is	  needed	  to	  determine	  
infection	  rate,	  herd	  
immunity	  and	  predicted	  
humoral	  protection,	  and	  
vaccine	  efficacy	  during	  
clinical	  trials	  and	  after	  
large-­‐scale	  vaccination	  
•   The	  current	  gold	  standard	  
requires	  live	  pathogen	  and	  
a	  biosafety	  level	  3	  
laboratory	  
•   Here	  results	  of	  a	  validated	  
simple	  and	  rapid	  surrogate	  
virus	  neutralisation	  test	  
are	  presented.	  This	  test	  
does	  not	  require	  biosafety	  
level	  3	  containment,	  
making	  it	  broadly	  
accessible	  to	  the	  wider	  
community	  for	  research	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   Journal/Article	  type	   Summary	  	  	  	  	  	  	  	  	  	  	  	   Keywords	  





	  	  NEJM	  |	  Article	   •   Glucocorticoids	  may	  
modulate	  inflammation-­‐











respiratory	  failure	  and	  
death	  
•   An	  open-­‐label	  trial	  in	  
patients	  who	  were	  
hospitalised	  with	  C19	  
randomly	  assigned	  to	  
receive	  oral	  or	  
intravenous	  
dexamethasone	  for	  up	  to	  
10	  days	  or	  to	  receive	  
usual	  care	  
•   Use	  of	  dexamethasone	  in	  
patients	  hospitalised	  with	  
C19	  resulted	  in	  lower	  28-­‐
day	  mortality	  among	  
those	  who	  were	  receiving	  
either	  invasive	  
mechanical	  ventilation	  or	  
oxygen	  alone	  at	  
randomisation.	  Not	  so	  in	  




















•   Early	  treatment	  with	  HCQ	  
in	  patients	  with	  mild	  C19	  
showed	  no	  benefit	  













Annals	  of	  Internal	  
Medicine	  |	  Article	  
	  	  
•   This	  randomised,	  double-­‐
blind,	  placebo-­‐controlled	  
trial	  showed	  that	  HCQ	  did	  
not	  substantially	  reduce	  























•   Preliminary	  results	  from	  
the	  RECOVERY	  trial	  
comparing	  HCQ	  vs.	  usual	  
care	  alone	  
•   HCQ	  was	  not	  associated	  
with	  reductions	  in	  28-­‐day	  
mortality	  in	  patients	  
hospitalised	  with	  C19,	  but	  
was	  associated	  with	  an	  
increased	  length	  of	  





	  	   increased	  risk	  of	  
progressing	  to	  invasive	  






Title/URL	   Journal/Article	  type	   Summary	   Keywords	  
20.07.2020	   Safety  and  
immunogenici













The	  Lancet	  |	  Article	   •   ChAdOx1	  nCoV-­‐19	  
showed	  an	  acceptable	  
safety	  profile	  and	  rapid	  
induction	  of	  both	  
humoral	  and	  cellular	  
immune	  responses	  
against	  SARS-­‐CoV-­‐2,	  with	  
increased	  responses	  after	  
a	  second	  dose	  
•   These	  results	  support	  
large-­‐scale	  evaluation	  of	  
this	  candidate	  vaccine	  in	  
























phase  2  trial	  
	  	  
The	  Lancet	  |	  Article	  
	  	  
•   Ad5-­‐vectored	  COVID-­‐19	  
vaccine	  showed	  an	  
acceptable	  safety	  profile	  
and	  rapid	  induction	  of	  
both	  humoral	  and	  cellular	  
immune	  responses	  
against	  SARS-­‐CoV-­‐2	  















Indirect  impact  of  COVID-­19  
Publication	  
date	  



















The	  Lancet	  |	  Article	  
	  	  
•   A	  comparison	  of	  the	  
health	  benefits	  of	  
sustaining	  routine	  
childhood	  immunisation	  
in	  Africa	  with	  the	  risk	  of	  
acquiring	  SARS-­‐CoV-­‐2	  
infection	  through	  visiting	  
routine	  vaccination	  
service	  delivery	  points	  
•   A	  high-­‐impact	  and	  low-­‐
impact	  scenario	  was	  
considered	  
•   Deaths	  prevented	  by	  
sustaining	  routine	  
childhood	  immunisation	  
in	  54	  African	  countries	  
outweighed	  the	  excess	  
risk	  of	  C19	  deaths	  
associated	  with	  
vaccination	  clinic	  visits,	  
especially	  for	  the	  
vaccinated	  children	  
•   Routine	  childhood	  
immunisation	  should	  be	  
safeguarded	  and	  
continued	  where	  
possible,	  given	  logistical	  
constraints,	  staff	  
shortages,	  and	  
reallocation	  or	  resources	  











19  crises 	  
UNOCHA	  |	  Report	   •   A	  taxonomy	  of	  the	  direct	  
and	  secondary	  costs	  
arising	  from	  not	  acting	  
now	  to	  contain	  the	  virus	  
and	  mitigate	  its	  cascading	  
effects	  
•   The	  cost	  of	  inaction	  
includes	  (1)	  the	  health	  
cost	  of	  failing	  to	  contain	  
C19	  domestically;	  (2)	  the	  
spill-­‐over	  costs	  of	  failing	  
to	  contain	  C19	  





economic	  costs	  of	  
protracted	  containment	  
measure	  on	  education;	  
(4)	  the	  human	  and	  
economic	  costs	  of	  
increased	  poverty	  and	  
hunger;	  (5)	  the	  cost	  of	  
increased	  global	  
instability	  and	  conflict	  
•   Scenarios	  presented	  to	  
showcase	  the	  differential	  
cost	  of	  inaction	  
•   Where	  relevant,	  a	  






Title/URL	   Journal/Article	  type	   Summary	   Keywords	  







CGD	  |	  Note	   •   Expected	  economic	  
contraction	  due	  to	  C19	  
will	  place	  pressure	  on	  
budgetary	  space	  for	  
health	  spending	  
•   Even	  maintaining	  
previous	  allocation	  levels	  
will	  be	  insufficient	  given	  
growing	  health	  needs	  as	  
a	  result	  of	  C19	  
•   There	  is	  uncertainty	  in	  
the	  volume	  and	  
destination	  of	  
development	  assistance	  
for	  health	  especially	  in	  
lower-­‐middle-­‐income	  
countries	  
•   Recommendations	  to	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Title/URL	   Journal	  |	  Article	  type	  
24.07.2020	   Our  response  to  COVID-­19  will  help  define  the  
21st  century 	  
Wellcome	  |	  Opinion	  
22.07.2020	   Building  Back  Better:  Creating  resilience  in  
critical  supply  chains  while  supporting  global  
development 	  
CGD	  |	  Blog	  
22.07.2020	   Age  is  just  a  number:  a  critically  important  
number  for  COVID-­19  case  fatality 	  
Annals	  of	  Internal	  Medicine	  |	  
Editorial	  
21.07.2020	   Lessons  from  Ebola  as  DRC  grapples  with  
conflict,  measles,  and  covid-­19 	  
BMJ	  |	  Feature	  Infection	  
Control	  
21.07.2020	   Disability  and  COVID-­19:  who  counts  depends  
on  who  is  counted 	  
The	  Lancet	  Public	  Health	  |	  
Correspondence	  
20.07.2020	   Encouraging  results  from  phase  1/2  COVID-­19  
vaccine  trials 	  
The	  Lancet	  |	  Comment	  
20.07.2020	   After  COVID-­19:  How  to  pull  off  the  SDG  hat-­
trick? 	  
CGD	  |	  Blog	  
20.07.2020	   Trial  of  COVID-­19  drug  given  via  inhaler  ‘very  
promising’,  say  scientists 	  
The	  Guardian	  |	  News	  
19.07.2020	   Covid-­19  in  Brazil  has  exposed  socio-­
economic  inequalities  and  underfunding  of  its  
public  health  system 	  
BMJ	  |	  Opinion	  
18.07.2020	   COVID-­19:  Africa  needs  unprecedented  
attention  to  strengthen  community  health  
systems 	  
The	  Lancet	  |	  Comment	  
18.07.2020	   New  funds  proposed  to  prevent  pandemics 	   The	  Lancet	  |	  World	  Report	  
17.07.2020	   Beyond  COVID-­19  (coronavirus):  What  will  be  
the  new  normal  for  health  systems  and  
universal  health  coverage? 	  
UHC2030	  |	  Blog	  
17.07.2020	   The  explosion  of  new  coronavirus  tests  that  
could  help  to  end  the  pandemic 	  
Nature	  |	  News	  Feature	  
15.07.2020	   The  price  of  inaction  during  the  COVID-­19  
crises 	  
CGD	  |	  Blog	  
13.07.2020	   An  effective  response  to  COVID-­19  is  an  
inclusive  response:  the  case  of  Uganda 	  
UHC2030	  |	  Blog	  
11.07.2020	   COVID-­19:  the  worst  may  be  yet  to  come 	   The	  Lancet	  |	  Editorial	  
	  
Guidelines,  Statements  &  Tools  
Publication	  
Date	  
Title/URL	   Source	   	  	  Summary	  
	  16.07.20	   	  Update  –  research  
and  development  





•   An	  update	  to	  the	  C19	  research	  
priorities	  in	  Africa	  
	  
8  
Dashboards  &  Trackers  
Cases	  &	  deaths:	  
Global	  
Cases	   &	  
deaths:	  
Regional	  










	  	  Diagnostics	   	  	  Treatments	   	  	  Vaccines	  
WHO  sitreps 	   WHO  
Africa 	  
Ghana 	   COVID-­
NMA 	  





































































US  NIH 	   	  Our  World  
in  Data:  
C19  Testing	  








Our  World  in  
Data 	  










	  	   	  	   	  	  
Global  5050 	  

















	  	   	  	   	  NIH  
LitCovid	  
	  UKCDR	   	  	   	  	   	  	  
Information  is  
Beautiful 	  




	  	   	  	   	  	   	  	  








	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  
C19  Resource  Hubs  

















LSTM 	   Stop  TB  
Partnership 	  






BMJ 	   LSHTM 	  
	  
	  	  IDA	  
WHO  Q&A 	   Nigeria  
CDC 	  
Bulletin  of  the  
WHO 	  
ICL  MRC  Centre  
for  Global  
Infectious  
Disease  Analysis 	  
Global  Menstrual  
Collective 	  

























Cell  Press 	   Johns  Hopkins  
University 	  



















UN  Women 	   Africa  
Evidence  
Network 	  
Elsevier 	   CMMID  
Repository 	  
	  	   	  	  






19  Digest 	  
Health  Policy  
and  Planning 	  
Norwegian  
Institute  of  Public  
Health 	  
	  	   	  	  






Oxford  Centre  for  
Evidence-­based  
Medicine 	  
	  	   	  	  
UNICEF 	   	  	   The  Lancet 	   	  HEART	   	  	   	  	  
10  
UNESCO 	   	  	   medRxiv  and  
bioRxiv	  (Prepr
ints)	  
	  UKRI	   	  	   	  	  
UN  WFP 	   	  	   NEJM 	   	  Evidence  Aid	   	  	   	  	  
GOARN 	   	  	   Oxford  
University  
Press 	  
	  NIH	   	  	   	  	  
EPI-­WIN 	   	  	   PLoS 	   IFPRI  Resources  
and  Analyses  of  
C19  Impact 	  
	  	   	  	  




	  	   	  	  
Our  World  
in  Data 	  





	  	   Springer  
Nature 	  
	  	   	  	   	  	  
Reliefweb 	   	  	   SSRN  
(Preprints)   	  




Map  Team 	  






nt  Data 	  
	  	  
	  
	  	   	  	   	  	  
WorldPop 	   	  	   	  	   	  	   	  	   	  	  
Flowminder 	   	  	   	  	   	  	   	  	   	  	  
COVID-­
END 	  






	           
	  	  
GISAID 	   	  	    	    	    	   	  	  
	  
	   	  
11  
Online  learning  &  events  
Date	   Title/URL	   Online	  
learning/event	  








Online	  event	   1h	  30	   Blavatnik	  School	  of	  
Government,	  
University	  of	  Oxford	  
June	  2020	   OpenWHO,  the  free,  
open-­access  learning  
platform  for  health  
emergencies,  now  
offers  10  online  
courses  related  to  
COVID19.	  











Nursing  in  Times  of  
Crisis 	  
Online	  course	   2	  weeks	  –	  2	  
hours	  per	  
week	  




WHO  Academy  and  
WHO  Info  mobile  
applications 	  





and  Policy 	  









11.5.2020	   COVID-­19  Contact  
Tracing  course 	  
Online	  learning	   5	  hours	   Johns	  Hopkins	  






5	  sessions	   1h	  30	   International	  Initiative	  











online  brief  with  Dr  
David  Nabarro 	  








and  control 	  






training  for  the  
coronavirus  disease  
outbreak 	  







the  Novel  Coronavirus 	  
















and  Testing 	  






6	  April	  2020	   COVID-­19  Critical  
Care:  Understanding  
and  Application 	  





of	  Edinburgh	  &	  Royal	  





online  courses 	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Evidence  Summary.  Brighton,  UK:  Institute  of  Development  Studies.    
Rapid  review  methodology    
The  rapid  daily  search  for  peer-­reviewed  literature  is  carried  out  through  a  PubMed  search  with  the  following  
keywords  (“COVID-­19”  OR  “severe  acute  respiratory  syndrome  coronavirus  2”  OR  “2019-­nCoV”  OR  “SARS-­
CoV2”  OR  “2019nCoV”  OR  “coronavirus”  )  AND  (“Africa”  OR  “South  Asia”  OR  “Developing”  OR  “low-­income”  OR  
“low  income”  OR  “lower-­middle  income”  OR  “low  and  middle  income”  OR  “LMIC”  OR  “LIC”  OR  “global  south”)  OR  
(“poverty”)  OR  (“equity”  OR  “equities”),  restricted  to  articles  published  in  the  previous  2  to  3  days,  in  English.  This  
is  complemented  by  a  search  of  the  homepage  of  the  following  high-­impact  global  health  journals:  The  Lancet  
journals,  New  England  Journal  of  Medicine,  Nature,  JAMA,  Annals  of  Internal  Medicine,  Cochrane  Reviews,  BMJ  
Global  Health,  the  PLoS  journals  and  a  Twitter  search  of  their  Twitter  pages.  A  search  also  of  preprints  from  
bioRxiv  and  medRxiv.  Please  note  that  papers  that  have  not  been  peer-­reviewed  are  highlighted  in  red.  All  
primary  research  papers  that  relate  to  the  primary  and  secondary  impacts  of  the  COVID-­19  response  in  LMICs,  
and  disease  control  and  health  system  responses  are  included.  Articles  related  to  tackling  the  secondary  impacts  
on  other  sectors  are  not  included.  Additional  commentaries,  opinions,  and  commissioned  pieces  are  selected  
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